Skip to main content
. 2012 Dec 3;5:425–431. doi: 10.2147/OTT.S38240

Figure 3.

Figure 3

Dose–survival curves fitted using a multi-target single-hitting model showing the impact of checkpoint kinase 2-small interfering RNA (CHK2-siRNA) in A549 cells treated with CpG oligodeoxynucleotide plus X-rays.

Notes: The sensitization enhancement ratio was higher in the CpG + X-ray group (1.46) than in the CHK2-siRNA + CpG + X-ray group (1.05).